首页> 外文期刊>Cardiorenal medicine >Reasons for Discontinuation of Lipid-Lowering Medications in Patients with Chronic Kidney Disease
【24h】

Reasons for Discontinuation of Lipid-Lowering Medications in Patients with Chronic Kidney Disease

机译:慢性肾脏病患者中止降脂药物的原因

获取原文
       

摘要

Abstract Background/Aims: Many patients with chronic kidney disease (CKD) do not receive lipid- lowering therapy despite their high cardiovascular risk. The reasons for this are unknown. Methods: We have conducted a retrospective cohort study of discontinuation of lipid-lower- ing drugs in patients with CKD stage 3 and higher treated in practices affiliated with two aca- demic medical centers between 2000 and 2010. Information on medication discontinuation and its reasons was o.
机译:摘要背景/目的:尽管许多慢性肾脏病(CKD)患者有较高的心血管风险,但他们并未接受降脂治疗。原因尚不清楚。方法:我们进行了一项回顾性队列研究,研究对象是2000年至2010年间在两家学术医学中心附属机构中治疗的CKD 3期及更高级别患者中止降脂药物。停药的信息及其原因是: o。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号